Header graphic for print
LimeGreenIP News

Brexit webinar – What’s next for Life Sciences companies?

BrexitWith the UK Government having issued its Article 50 notice, we are holding a webinar to further analyse the implications for the life sciences sector of the momentous decision that the UK has made to leave the EU. On 3 April 12:00 pm BST and 5 April 4:00 pm BST, our Life Sciences lawyers Charles Brasted, Elisabethann Wright, Fabien Roy, Helen Kimberley and Sahira Khwaja will discuss:

  • What is the likely process from the serving of the Article 50 notice to the UK leaving the EU?
  • What effect might Brexit have for existing and future marketing authorisations for medicinal products?
  • How might medical device manufacturers be affected?
  • How does the decision affect commercial contracts?
  • What are the questions you should consider from an IP perspective?
  • Is there anything you should do immediately?
  • How can your businesses influence what happens next?

Click here to register and read for more information